{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:03:01Z","timestamp":1789448581072,"version":"build-2803163510"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Immune checkpoint inhibitor (ICI)-associated myocarditis is a rare but potentially fatal immune-related adverse event lacking reliable biomarkers for risk stratification. This exploratory pilot case-control study aimed to characterize baseline plasma metabolomic profiles in patients who developed ICI-associated myocarditis and to evaluate a metabolite-based predictive model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Baseline plasma samples from 15 patients with ICI-associated myocarditis and 15 matched controls were analyzed by untargeted metabolomics using UHPLC-Q\/Orbitrap HRMS. Differential metabolites were identified by OPLS-DA and univariate analysis. A metabolite-derived PC1 was used in logistic regression models (clinical-only, metabolite-only, combined), with performance assessed by AUC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Ten differential metabolites were identified, implicating glutathione metabolism, phenylalanine metabolism, and histidine metabolism pathways. Key alterations included elevated phenylpyruvic acid, 1-methylpseudouridine, cinnamoylglycine, pyroglutamic acid and spermine, with decreased ceramide, cyclo-prolylglycine, propionic acid, glycolic acid, and histamine. A clinical model incorporating three baseline laboratory variables (lymphocyte ratio, monocyte ratio, and eosinophil ratio) achieved an AUC of 0.618. The metabolite PC1 model alone attained an AUC of 0.964, outperforming the clinical model. The combined clinical-metabolite model reached a fitted AUC of 0.973 (cross-validated AUC 0.925). Decision curve analysis indicated that the combined model provided potential net benefit within the 20%-40% threshold range, marginally exceeding the metabolite-only model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This exploratory study identified baseline plasma metabolites potentially associated with ICI-associated myocarditis risk, implicating oxidative stress, immune modulation, and gut microbiota-host interactions. The metabolite-based model showed preliminary discriminative ability, but prospective validation in independent cohorts is required.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1915039","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T04:27:22Z","timestamp":1789446442000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Discovery of plasma metabolomic biomarkers and a predictive model for immune checkpoint inhibitor-associated myocarditis: a pilot case-control study"],"prefix":"10.3389","volume":"17","author":[{"given":"Zhuoling","family":"Zheng","sequence":"first","affiliation":[{"name":"Department of Pharmacy, The Sixth Affiliated Hospital, Sun Yat-Sen University","place":["Guangzhou, Guangdong, China"]},{"name":"Guangzhou (Huangpu) Zhongliu Biomedical Innovation Center","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingling","family":"Gu","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Sun Yat-sen University","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiting","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Sixth Affiliated Hospital, Sun Yat-Sen University","place":["Guangzhou, Guangdong, China"]},{"name":"Guangzhou (Huangpu) Zhongliu Biomedical Innovation Center","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Sixth Affiliated Hospital, Sun Yat-Sen University","place":["Guangzhou, Guangdong, China"]},{"name":"Guangzhou (Huangpu) Zhongliu Biomedical Innovation Center","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Sixth Affiliated Hospital, Sun Yat-Sen University","place":["Guangzhou, Guangdong, China"]},{"name":"Guangzhou (Huangpu) Zhongliu Biomedical Innovation Center","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Sixth Affiliated Hospital, Sun Yat-Sen University","place":["Guangzhou, Guangdong, China"]},{"name":"Guangzhou (Huangpu) Zhongliu Biomedical Innovation Center","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Li","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Sun Yat-sen University","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Sixth Affiliated Hospital, Sun Yat-Sen University","place":["Guangzhou, Guangdong, China"]},{"name":"Guangzhou (Huangpu) Zhongliu Biomedical Innovation Center","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1038\/s41467-020-17670-y","article-title":"A decade of immune-checkpoint inhibitors in cancer therapy","volume":"11","author":"Robert","year":"2020","journal-title":"Nat Commun"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1609214","article-title":"Fulminant myocarditis with combination immune checkpoint blockade","volume":"375","author":"Johnson","year":"2016","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.3923","article-title":"Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis","volume":"4","author":"Wang","year":"2018","journal-title":"JAMA Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-023-01320-5","article-title":"Cardiovascular toxicity of immune checkpoint inhibitors: a guide for clinicians","volume":"46","author":"Raschi","year":"2023","journal-title":"Drug Saf"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30608-9","article-title":"Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study","volume":"19","author":"Salem","year":"2018","journal-title":"Lancet Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.013757","article-title":"Immune checkpoint inhibitor myocarditis: pathophysiological characteristics, diagnosis, and treatment","volume":"9","author":"Palaskas","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113559","article-title":"Insight of immune checkpoint inhibitor related myocarditis","volume":"143","author":"Pi","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa051","article-title":"Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis","volume":"41","author":"Zhang","year":"2020","journal-title":"Eur Heart J"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1597259","article-title":"Management of immune-related myocarditis, myositis and myasthenia gravis (MMM) overlap syndrome: a single institution case series and literature review","volume":"16","author":"Sanchez-Camacho","year":"2025","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1080\/004982599238047","article-title":"'metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data","volume":"29","author":"Nicholson","year":"1999","journal-title":"Xenobiotica"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-0998.2010.02854.x","article-title":"Metabolomics: the chemistry between ecology and genetics","volume":"10","author":"Macel","year":"2010","journal-title":"Mol Ecol Resour"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.09.972","article-title":"The emerging role of metabolomics in the diagnosis and prognosis of cardiovascular disease","volume":"68","author":"Ussher","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2025.2547271","article-title":"Low triglyceride levels are associated with increased risk of immune-related adverse events in patients receiving immune checkpoint inhibitors","volume":"14","author":"M\u00f6hn","year":"2025","journal-title":"Oncoimmunology"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009399","article-title":"Plasma metabolomics of immune-related adverse events for patients with lung cancer treated with PD-1\/PD-l1 inhibitors","volume":"12","author":"Chen","year":"2024","journal-title":"J Immunother Cancer"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114676","article-title":"L-kynurenine regulates immune response in ICIs-associated myocarditis via JAK\/STAT pathway","volume":"156","author":"He","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1762144","article-title":"Integrated risk stratification for ICI-associated myocarditis: a baseline hematological profile and a combined ECG and enzymatic signature at onset","volume":"17","author":"Zheng","year":"2026","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1093\/eurheartj\/ehaf192","article-title":"2025 ESC guidelines for the management of myocarditis and pericarditis","volume":"46","author":"Schulz-Menger","year":"2025","journal-title":"Eur Heart J"},{"key":"B18","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1093\/rheumatology\/keaa126","article-title":"Metabolomic profiling reveals serum l-pyroglutamic acid as a potential diagnostic biomarker for systemic lupus erythematosus","volume":"60","author":"Zhang","year":"2021","journal-title":"Rheumatology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1472-8206.1988.tb00623.x","article-title":"A new endogenous anxiolytic agent: l-pyroglutamic acid","volume":"2","author":"Beni","year":"1988","journal-title":"Fundam Clin Pharmacol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2018.08.001","article-title":"LC-MS analysis of key components of the glutathione cycle in tissues and body fluids from mice with myocardial infarction","volume":"160","author":"Gil","year":"2018","journal-title":"J Pharm BioMed Anal"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13080923","article-title":"A systematic review on advances in management of oxidative stress-associated cardiovascular diseases","volume":"13","author":"Jin","year":"2024","journal-title":"Antioxidants"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1550400","article-title":"ICI-induced cardiovascular toxicity: mechanisms and immune reprogramming therapeutic strategies","volume":"16","author":"Zheng","year":"2025","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.06.051","article-title":"Regulation of the immune response and inflammation by histamine and histamine receptors","volume":"128","author":"O'Mahony","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2011.10.004","article-title":"Histamine h(1) receptor signaling regulates effector t cell responses and susceptibility to coxsackievirus b3-induced myocarditis","volume":"272","author":"Case","year":"2012","journal-title":"Cell Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00380-010-0018-z","article-title":"A novel phenylpyridazinone, t-3999, reduces the progression of autoimmune myocarditis to dilated cardiomyopathy","volume":"26","author":"Kamal","year":"2011","journal-title":"Heart Vessels"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.177477","article-title":"Spermine alleviates myocardial cell aging by inhibiting mitochondrial oxidative stress damage","volume":"997","author":"Yang","year":"2025","journal-title":"Eur J Pharmacol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-024-01014-8","article-title":"Short-chain fatty acids: linking diet, the microbiome and immunity","volume":"24","author":"Mann","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"5370","DOI":"10.1038\/s41467-022-33050-0","article-title":"An online atlas of human plasma metabolite signatures of gut microbiome composition","volume":"13","author":"Dekkers","year":"2022","journal-title":"Nat Commun"},{"key":"B29","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41571-025-01026-w","article-title":"Roles of the gut microbiota in immune-related adverse events: mechanisms and therapeutic intervention","volume":"22","author":"Gao","year":"2025","journal-title":"Nat Rev Clin Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaf093","article-title":"Ceramides in cardiovascular disease: emerging role as independent risk predictors and novel therapeutic targets","volume":"121","author":"Klingenberg","year":"2025","journal-title":"Cardiovasc Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111412","article-title":"Lipidomics reveals immune-related adverse events in NSCLC patients receiving immune checkpoint inhibitor","volume":"127","author":"Yu","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/jleuko\/qiad056","article-title":"Peripheral immune mapping and multi-omics analysis in pd-1 inhibitor-induced myocarditis","volume":"114","author":"Gao","year":"2023","journal-title":"J Leukoc Biol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/s0895-4356(96)00236-3","article-title":"A simulation study of the number of events per variable in logistic regression analysis","volume":"49","author":"Peduzzi","year":"1996","journal-title":"J Clin Epidemiol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1915039\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T04:27:24Z","timestamp":1789446444000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1915039\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":33,"alternative-id":["10.3389\/fimmu.2026.1915039"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1915039","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"article-number":"1915039"}}